Prevention of neurotoxicity by high-dose folinic acid rescue after high-dose methotrexate and intrathecal methotrexate without compromising cure inspite of previous transient leukoencephalopathy after intrathecal methotrexate.
Hamidah
Alias
A
Raja Lope
Raja Juanita
RJ
Abdul Latiff
Zarina
Z
Anuar
Zulfiqar M
ZM
Jamal
Rahman
R
D002648:Child; D005492:Folic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D005493:Folic Acid Antagonists / Q000009:adverse effects*; D006397:Hematinics / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006987:Hypesthesia / Q000139:chemically induced / Q000188:drug therapy; D007278:Injections, Spinal; D056784:Leukoencephalopathies / Q000139:chemically induced*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D011782:Quadriplegia / Q000139:chemically induced / Q000188:drug therapy*; D013997:Time Factors; D014803:Vitamin B Complex / Q000008:administration & dosage / Q000627:therapeutic use*
D005493:Folic Acid Antagonists; D006397:Hematinics; D014803:Vitamin B Complex; D005492:Folic Acid; D008727:Methotrexate